Inhibition of protein kinase C-dependent protein phosphorylation correlates with increased polarity and locomotion in Walker 256 carcinosarcoma cells

International Journal of Cancer

Volumn 65, Issue 4, 1996, Pages 473-478

  Niggli, Verena ^a   Zimmermann, Arthur ^a   Keller, Hansuli ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

2 [1 (3 AMIDINOTHIOPROPYL) 1H INDOL 3 YL] 3 (1 METHYL 1H INDOL 3 YL)MALEIMIDE; MIDOSTAURIN; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN KINASE C; PROTEIN KINASE INHIBITOR;

ARTICLE; CELL CULTURE; CELL MIGRATION; CELL SHAPE; CONTROLLED STUDY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SARCOMA CELL; SIGNAL TRANSDUCTION; WALKER CARCINOMA;

ANIMALS; CARCINOMA 256, WALKER; CELL MOVEMENT; CELL POLARITY; HUMANS; INDOLES; PHOSPHORYLATION; PROTEIN KINASE C; PROTEINS; TETRADECANOYLPHORBOL ACETATE; TUMOR CELLS, CULTURED;

EID: 0029974660     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19960208)65:4<473::AID-IJC14>3.0.CO;2-B     Document Type: Article

References (21)

1. ANDO, Y., LAZARUS, G.S and JHNSEN, P.J., Activation of protein kinase C inhibits human keratinocyte migration. J. cell, Phvsiol., 156, 487-496 (1993).
2. BLACKSHEAR, P.J., The MARCKS family of cellular protein kinase C substrates. J. biol Chem., 268, 1501-1504 (1993)
3. BUDWORTH, J. and GESCHER, A., Differential inhibition of cytosolic and membrane-derived protein kinase C activity by staurospornine and other kinase inhibitors. FEBS Lett., 362, 139-142 (1995)
4. COURAGE, C., BUDWORTH, J. and GESCHER, A., Comparison of ability of protein Kinase C inhibitors to arrest cell growth and to alter cellular protein kinase C localisation. Brit J. Cancer, 71, 697-704 (1995).
5. FRIDMAN, R., LACAL, J.C., REICH, R., BONFIL, D. and AHN, C-H., Differential effects of phorbol ester on the in vitro mvasiveness of malignant and non-malignant human fibroblast cells. J cell. Physiol., 142, 35-60 (1990).
6. HUG, H. and SARRE, T.F., Protein kinase C isoenzymes: divergence in signal transduction? Biochem. J., 291, 329-343 (1993)
7. JANIK, P., SZANIAWSKA, B., KOWALCZYK, D. and MILOSZEWSKA, J., The effect of phorbol ester treatment on migration of C3H 10T1/2 and BT5C glioma cells: possible application to carcinogenesis. J. Cancer Res. clin. Oncol., 120, 156-158 (1994).
8. KELLER, H.U. and NIGGLI, V., Selective effects of the PKC inhibitors Ro 31-8220 and CGP 41 251 on PMN locomotion, cell polarity, and pinocytosis. J. cell. Physiol., 161, 526-536 (1994).
9. KELLER, H.U. and ZIMMERMANN, A., Shape changes and chemokinesis of Walker 256 carcinosarcoma cells in response to colchicine. vinblastine. nocodazole and taxol. Invasion Metastasis, 6, 33-43 (1986).
10. KELLER, H.U., ZIMMERMANN, A. and COTTIER, H., Phorbol myristate acetate (PMA) suppresses polarization and locomotion and alters F-actin content of Walker carcinosarcoma cells. Int. J. Cancer, 36, 495-501 (1985).
11. KELLER, H.U., ZIMMERMANN, A. and NIGGLI, V., Diacylglycerols and the protein kinase inhibitor H-7 suppress cell polarity and locomotion of Walker 256 carcinosarcoma cells. Int. J. Cancer, 44, 934-939 (1989).
12. 4. Nature (Lond.), 227, 680-685 (1970).
13. LIOTTA, L.A., STEEG, P.S. and STETLER-STEVENSON, W.G., Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell, 64, 327-336 (1991).
14. MARTHE, M., MEIER, T., STABEL, S., JAKEN, S., FABBRO, D. and HYNES, N.E., Protein kinase C and mammary cell differentiation: an essential role for PKC-α in the induction of β-casein expression. Cell Growth Differentiation, 5, 239-247 (1994).
15. MEYER, T., REGENASS, U., FABBRO, D., ALTERI, E., RÖSEL, J., MÜLLER, M., CARAVATTI, G. and MATTER, A., A derivative of staurosporine (CGP 41 251) shows selectivity for protein kinase C inhibition and in vitro antiproliferative as well as in vivo anti-tumor activity. Int J. Cancer, 43, 851-856 (1989).
16. Roos, F.J., ZIMMERMANN, A. and KELLER, H.U., Effect of phorbol myristate acetate and the chemotactic peptide fNLPNTL on shape and movement of human neutrophils. J. Cell Sci., 88, 399-406 (1987).
17. TWOMEY, B., MUID, R.E., NIXON, J.S., SEDGWICK, A.D., WILKINSON, S.E. and DALE, M.M., The effect of new potent selective inhibitors of protein kinase C on the neutrophil respiratory burst. Biochem. biophys. Res. Comm., 171, 1087-1092 (1990).
18. WEYMAN, C.M., TAPAROWSKY, E.J., WOLFSON, M. and ASHENDEL, C.L., Partial down-regulation of protein kinase C in C3H 10T1/2 mouse fibroblasts transfected with the human Ha-ras oncogene. Cancer Res., 48, 6535-6541 (1988).
19. WILKINSON, S.E., PARKER, P.J. and NIXON, J.S., Isoenzyme specificity of bisindolmaleimides, selective inhibitors of protein kinase C. Biochem. J., 294, 335-337 (1993).
20. ZIMMERMANN, A. and KELLER, H.U., Effects of staurosporine. K 252a and other structurally related protein kinase inhibitors on shape and locomotion of Walker carcinosarcoma cells. Brit. J. Cancer, 66, 1077-1082 (1992).
21. ZIMMERMANN, A. and KELLER, H.U., Shape changes and chemokinesis of Walker carcinosarcoma cells: effects of protein kinase inhibitors (HA-1004, polymyxin B, sangivamycin and tamoxifen) and an inhibitor of diacylglycerol kinase (R 59022). Anticancer Res., 13, 347-354 (1993).